Polymeric networks for controlled release of drugs: a patent review

Expert Opinion on Therapeutic Patents

Volumn 26, Issue 6, 2016, Pages 703-717

  du Toit, Lisa C ^a   Choonara, Yahya E ^a   Kumar, Pradeep ^a   Pillay, Viness ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Controlled drug delivery; crosslinking; drug delivery systems; hydrogels; interpenetrating polymer networks; patents; polymer network; stimulus responsive drug delivery systems

Indexed keywords

POLYMER; DELAYED RELEASE FORMULATION; DRUG; NANOPARTICLE;

BIOCOMPATIBILITY; BIODEGRADABILITY; CONFORMATIONAL TRANSITION; CONTROLLED DRUG RELEASE; COVALENT BOND; CROSS LINKING; CRYSTAL STRUCTURE; CRYSTALLIZATION; DISPERSION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; ELASTICITY; GLASS TRANSITION TEMPERATURE; HEAT TOLERANCE; HUMAN; HYDROGEL; HYDROGEN BOND; INTRACELLULAR TRANSPORT; IONIC STRENGTH; MELTING POINT; MICELLIZATION; MICROENCAPSULATION; MOLECULAR INTERACTION; MOLECULAR WEIGHT; MULTICENTER STUDY (TOPIC); PARTICLE SIZE; PATENT; PH; POLYMERIZATION; REVIEW; TEMPERATURE; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DESIGN;

ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; NANOPARTICLES; PATENTS AS TOPIC; PHARMACEUTICAL PREPARATIONS; POLYMERS;

EID: 84966472173     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1080/13543776.2016.1178720     Document Type: Review

References (95)

1. S.Grund, M.Bauer, D.Fischer Polymers in drug delivery-state of the art and future trends. Adv Engineer Mater. 2011;13:B61–B87.
2. P.Agrawal. Significance of polymers in drug delivery system. J Pharmacovigil. 2015;3:e127.
3. A.D.Jenkins, P.Kratochvíl, R.F.T.Stepto, et al. IUPAC, Glossary of basic terms in polymer science. Pure Appl Chem. 1996;68:2287. (Def. 1.58)
4. Y.-S.Ye, J.Rick, B.-J.Hwang. Water soluble polymers as proton exchange membranes for fuel cells. Polym. 2012;4:913–963.
5. J.-Y.Sun, X.Zhao, W.R.K.Illeperuma, et al. Highly stretchable and tough hydrogels. Nature. 2012;489:133–136.
6. C.Gonçalves, P.Pereira, M.Gama. Self-assembled hydrogel nanoparticles for drug delivery applications. Materials. 2010;3:1420–1460.
7. B.Erman, J.E.Mark. The molecular basis of rubberlike elasticity. In: J.E.Mark, B.Erman, F.R.Eirich, editors. Science and technology of rubber. 2nd ed. San Diego (CA): Academic Press; 1994.
8. L.H.Sperling. First published: ACS Division of Polymeric Materials: Science and Engineering (PMSE). 1999. 79.
9. A.D.Jenkins, J.Kahovec, P.Kratochvíl, et al. IUPAC, Source-based nomenclature for non-linear macromolecules and macromolecular assemblies. Pure Appl Chem. 1997;69:2511.
10. S.C.Kim, L.H.Sperling, editors. IPNs around the world: science and engineering. Chichester, England: Wiley; 1997.
11. E.M.Ahmed. Hydrogel: preparation, characterization, and applications: A review. J Adv Res. 2015;6:105–121.
12. W.B.Liechty, D.R.Kryscio, B.V.Slaughter, et al. Polymers for drug delivery systems. Annu Rev Chem Biomol Eng. 2010;1:149–173.•• Excellent insight into intelligent polymeric drug delivery systems.
13. S.S.Pedrosa, C.Gonçalves, L.David, et al. A novel crosslinked hyaluronic acid nanogel for drug delivery. Macromol Biosci. 2014;14:1556–1568.
14. J.H.Ryu, R.T.Chacko, S.Jiwpanich, et al. Self-cross-linked polymer nanogels: a versatile nanoscopic drug delivery platform. J Am Chem Soc. 2010;8(132):17227–17235.
15. K.Madhusudana Rao, K.Rao, G.Ramanjaneyulu, et al. Curcumin encapsulated pH sensitive gelatin based interpenetrating polymeric network nanogels for anti cancer drug delivery. Int J Pharm. 2015;478:788–795.
16. W.L.Zhang, B.Guo, X.P.Ma. Cytocompatible injectable carboxymethyl chitosan/N-isopropylacrylamide hydrogels for localized drug delivery. Carbohydr Polym. 2014;103:110–118.
17. S.Kaity, J.Isaac, A.Ghosh. Interpenetrating polymer network of locust bean gum-poly (vinyl alcohol) for controlled release drug delivery. Carbohydr Polym. 2013;15:456–467.
18. Q.Xu, W.Huang, L.Jiang, et al. KGM and PMAA based pH-sensitive interpenetrating polymer network hydrogel for controlled drug release. Carbohydr Polym. 2013;97:565–570.
19. S.S.Bhattacharya, A.K.Ghosh, S.Banerjee, et al. Al3+ ion cross-linked interpenetrating polymeric network microbeads from tailored natural polysaccharides. Int J Biol Macromol. 2012;51:1173–1184.
20. K.Kumari, P.P.Kundu. Studies on in vitro release of CPM from semi-interpenetrating polymer network (IPN) composed of chitosan and glutamic acid. Bull Mater Sci. 2008;3:159–167.
21. P.V.Kulkarni, J.Keshavayya. Chitosan-sodium alginate biodegradable interpenetrating polymer network (IPN) beads for delivery ofofloxacin hydrochloride. Int J Pharm Pharmaceut Sci. 2010;2:77–82.
22. R.Boppana, R.V.Kulkarni, S.S.Mutalik, et al. Interpenetrating network hydrogel beads of carboxymethylcellulose and egg albumin for controlled release of lipid lowering drug. J Microencap. 2010;27:337–344.
23. J.Malakar, A.K.Nayak, D.Pal. Development of cloxacillin loaded multiple-unit alginate-based floating system by emulsion-gelation method. Int J Biol Macromol. 2012;50:138–147.
24. V.Pillay, R.Fassihi. Electrolyte-induced compositional heterogeneity: a novel approach for rate-controlled oral drug delivery. J Pharm Sci. 1999;88:1140–1148.
25. A.Nochos, D.Douroumis, N.Bouropoulos. In vitro release of bovine serum albumin from alginate/HPMC hydrogel beads. Carbohydr Polym. 2008;74:451–457.
26. K.H.Leong, L.Y.Chung, M.I.Noordin, et al. Lectin-functionalized carboxymethylated kappa-carrageenan microparticles for oral insulin delivery. Carbohydr Polym. 2011;86:555–565.
27. K.S.V.Krishna Rao, B.Vijaya Kumar Naidu, M.C.S.Subha, et al. Novel chitosan-based pH-sensitive interpenetrating network microgels for the controlled release of cefadroxil. Carbohydr Polym. 2006;66:333–344.
28. R.V.Kulkarni, V.Sreedhar, S.Mutalik, et al. Interpenetrating network hydrogel membranes of sodium alginate and poly(vinyl alcohol) for controlled release of prazosin hydrochloride through skin. Int J Biol Macromol. 2010;47:520–527.
29. M.Sinha, R.M.Banik, C.Haldar, et al. Development of ciprofloxacin hydrochloride loaded poly(ethylene glycol)/chitosan scaffold as wound dressing. J Por Mater. 2013;20:799–807.
30. R.A.Siegel, M.J.Rathbone. Overview of controlled release mechanisms. In: J.Siepmann, Siegel RA, Rathbone MJ editors. Fundamentals and applications of controlled release drug delivery, advances in delivery science and technology. # Controlled Release Society. New York: Springer US; 2012.
31. H.Wen, K.Park, editors. Oral controlled release formulation design and drug delivery: theory to practice. New Jersey: John Wiley & Sons; 2011.
32. R.Langer, N.A.Peppas. Advances in biomaterials, drug delivery, and bionanotechnology. AIChE J. 2003;49:2990–3006.
33. A.Heller. Integrated medical feedback systems for drug delivery. AIChE J. 2005;51:1054–1066.
34. Z.Li, X.Yang, L.Wu, et al. Synthesis, characterization and biocompatibility of biodegradable elastomeric poly(ether-ester urethane)s based on poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) and poly(ethylene glycol) via melting polymerization. J Biomater Sci Polym Ed. 2009;20:1179–1202.
35. L.Tt. Compose Element Limited, Taipei. Method of preparing hydrogel structure. US 8,877,169 B2. 2014.
36. Y.Fu, W.J.Kao. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin Drug Deliv. 2010;7:429–444.
37. R.S.Langer, J.H.Elisseeff, K.Anseth, et al. Massachusetts Institute of Technology. Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering. US 6,224,893 B1. 2001.
38. R.S.Langer, J.H.Elisseeff, K.Anseth, et al. Massachusetts Institute of Technology. Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering. US 7,625,580 B1. 2009.
39. E.Caló, V.V.Khutoryanskiy. Biomedical applications of hydrogels: A review of patents and commercial products. Eur Polym J. 2015;65:252–267.
40. N.R.F.Beeley, B.A.Coldren, V.Lust, Johnson & Johnson Vision Care, Inc. Punctal plug containing drug formulation. US 8,821,457 B2. 2014.
41. A.S.Sawhney, P.Jarrett, M.Bassett, et al. Incept, LLC. Drug delivery through hydrogel plugs. US 8,409,606 B2. 2013.
42. R.F.Tester, J.Karkalas, Glycologic Limited. Orally administrable compositions comprising cation cross-linked polysaccharide and a polymer digestible in the lower gastrointestinal tract. US 6,649,191 B1. 2003.
43. Ocular Therapeutix™. 2016. Available from: www.ocutx.com
44. C.D.Claude, Advanced Cardiovascular Systems, Inc. Controlled morphologies in polymer drug for release of drugs from polymer films. US 7,364,748 B2. 2008.
45. M.L.Rue, D.S.Tierney, Endo Pharmaceuticals Solutions, Inc. Implantation device for subcutaneous implantation of an object under the skin. US 7,850,639 B2. 2010.
46. Cervidil website. Available from: www.cervidil.com.2015
47. B.V.Ferring. Misoprostol composition. EP 2,689,781 A1 20140129 (EN). 2014.
48. K.S.Albert, P.J.Maes, Bioavail Laboratories International SRL. Chronotherapeutic diltiazem formulations and the administration thereof. US 7,108,866. 2006.
49. J.P.Remon, Universiteit Gent. Cushioning wax beads for making solid shaped articles. US 6,923,984. 2005.
50. W.E.Hennink, W.N.E.van Dijk-Wolthuis.Hydrolysable hydrogels for controlled release. US 7,060,296 B2. 2006.
51. K.Park, W.Shalaby, H.Paark. Biodegradable hydrogels for drug delivery. Lancaster, PA: Technomic; 1993.
52. L.S.Nair, C.T.Laurencin. Biodegradable polymers as biomaterials. Prog Polym Sci. 2007;32:762–798.
53. R.Dorati, I.Genta, C.Colonna, et al. Investigation of the degradation behavior of poly(ethylene glycol-co-D,L-lactide) copolymer. Polym Degrad Stabil. 2007;92:1660–1668.
54. Y.Zhang, H.F.Chan, K.W.Leong. Advanced materials and processing for drug delivery: the past and the future. Adv Drug Deliv Rev. 2013;65:104–120.• Good review highlighting commercialized drug delivery systems.
55. R.T.Lyons, J.A.Burke, M.R.Robinson, Allergan, Inc. Biodegradable drug delivery system. US 8,956,655 B2. 2015.
56. O.A.Kolawole, V.Pillay, Y.E.Choonara, University of the Witwatersrand. Polyamide rate-modulated monolithic drugdelivery system. US 8,277,841 B2. 2012.
57. Y.Huang, W.Li, D.Yan. Crystalline transition of nylons 12, 20 and 10, 20. Eur Polym J. 2003;39:1133–1140.
58. X.Cui, D.Yan. Preparation, characterization and crystalline transitions of odd-even polyamides 11, 12 and 11,10. Eur Polym J. 2005;41:863–870.
59. X.Cui, Z.Liu, D.Yan. Synthesis and characterization of novel even–odd nylons based on undecanedioic acid. Eur Polym J. 2004;40:1111–1118.
60. N.A.Jones, E.D.T.Atkins, M.J.Hill, et al. Chain-folded lamellar crystals of aliphatic polyamides. Investigation of nylons 4 8, 4 10, 4 12, 6 10, 6 12, 6 18, and 8 12. Polymer. 1997;38:2689–2699.
61. O.A.Kolawole, V.Pillay, Y.E.Choonara. Novel polyamide 6,10 variants synthesized by modified interfacial polymerization for application as a rate-modulated monolithic drug delivery system. J Bioact Compat Polym. 2007;22:281–313.
62. E.S.Gil, S.A.Hudson. Stimuli-reponsive polymers and their bioconjugates. Prog Polym Sci. 2004;29:1173–1222.
63. D.Schmaljohann. Thermo- and pH-responsive polymers in drug delivery. Adv Drug Deliv Rev. 2006;58:1655–1670.
64. H.G.Schild. Poly (N-isopropylacrylamide): experiment, theory and application. Prog Polym Sci. 1992;17:163–249.
65. A.R.Khare, N.A.Peppas. Swelling/deswelling of anionic copolymer gels. Biomaterials. 1995;16:559–567.
66. M.Malmsten, B.Lindman. Self-assembly in aqueous block copolymer solutions. Macromolecules. 1992;25:5440–5445.
67. M.D.C.Topp, P.J.Dijkstra, H.Talsma, et al. Thermosensitive micelle-forming block copolymers of poly(ethylene glycol) and poly(N-isopropylacrylamide). Macromolecules. 1997;30:8518–8520.
68. M.Behl, A.Lendlein. Shape-memory polymers. Mater Today. 2007;10:20–28.
69. L.C.du Toit, T.Marimuthu, P.Kumar, et al. Customized shape memory biopolymers. In: V.Pillay, Y.E.Choonara, P.Kumar, editors. Unfolding the biopolymer landscape. Vol. 2. Sharjah: Bentham Science Publishers; 2016. p. 92–123.
70. M.Ebara. Shape-memory surfaces for cell mechanobiology. Sci Technol Adv Mater. 2015;16:014804.
71. P.I.Lee, C.J.Kim. Probing the mechanisms of drug release from hydrogels. J Control Rel. 1991;16:229–236.
72. C.Wu, S.Jiang, The Chinese University Of Hong Kong. Polymer gel composition and uses therefore. US 6,030,634 A. 2000.
73. J.Turner, Y.L.Cheng. Process for preparing interpenetrating polymer networks of controlled morphology. US 6,331,578 B1. 2001.
74. A.Lendlein, A.Schmidt, Mnemoscience GmbH. Interpenetrating networks. US 7,037,984 B2. 2006.
75. G.M.Zentner, J.S.Bark, F.Liu, Macromed, Inc. Polymer blends that swell in an acidic environment and deswell in a basic environment. US 7,182,957 B2. 2007.
76. Z.Hu, X.Xia, University Of North Texas. Aqueous dispersion of hydrogel nanoparticles with inverse thermoreversible gelation. US 8,048,450 B2. 2011.
77. S.D.Lee, B.S.Kim, M.K.Nguyen, Sungyunkwan University Foundation Collaboration. Poly(amidoamine) oligomer hydrogel for drug delivery and drug carrier using the same. US 8,383,153 B2. 2013.
78. A.Rosenthal, J.J.Barry, R.Sahatjian, Boston Scientific Scimed Inc. Triggered release hydrogel drug delivery system. US 7,066,904 B2. 2006.
79. J.Y.Ying, T.C.Zion, A.Zarur, Massachusetts Institute of Technology. Stimuli-responsive systems for controlled drug delivery. US 8,357,400 B2. 2013.
80. R.S.Langer, A.Lendlein, A.Schmidt, et al. Massachusetts Institute of Technology. Biodegradable shape memory polymers. US 6,160,084 A. 2000.
81. A.Lendlein, R.Langer. Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science. 2002;296:1673–1676.
82. A.Lendlein, M.Behl, B.Hiebl, et al. Shape-memory polymers as a technology platform for biomedical applications. Expert Rev Med Device. 2010;7:357–379.
83. S.Hayashi, Mitsubishi Jukogyo Kabushiki Kaisha. Shape memory polyurethane elastomer molded article. US 5,145,935 A. 1992.
84. A.Lendlein, A.M.Schmidt, M.Schroeter, et al. Shape-memory polymer networks from oligo(ϵ-caprolactone)dimethacrylates. J Polym Sci Part A: Polym Chem. 2005;43:1369–1381.
85. R.Gref, Y.Minamitake, M.T.Peracchia, et al. Biodegradable long-circulating polymeric nanospheres. Science. 1994;263:1600–1603.
86. D.E.Owens, N.A.Peppas, University of Texas. Temperature-sensitive nanoparticles for controlled drug delivery. WO2008039920. 2008.
87. W.D.Athawale, S.L.Kolekar, S.S.Raut. Recent developments in polyurethanes and poly(acrylates) interpenetrating polymer networks. J Macromol Sci-Polym Rev. 2003;C43:1–26.
88. H.Katono, A.Maruyama, K.Sanui, et al. Thermoresponsive swelling and drug release switching of interpenetrating polymer networks composed of poly (acrylamide-co-butyl methacrylate) and poly (acrylic-acid). J Control Release. 1991;16:215–227.
89. N.Alcantar, K.Dearbon, E.Hood, et al. University of South Florida. Niosome-hydrogel drug delivery. WO2007123993 A2. 2007.
90. ClinicalTrials.gov. Exploratory study of the cutaneous penetration of biodegradable polymeric microparticles in atopic dermatitis (MicroIskin). NCT02369432. 2016. https://clinicaltrials.gov/ct2/show/NCT02369432?term=polymeric+drug+delivery+system&rank=1
91. S.Mura, J.Nicolas, P.Couvreur. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013;12:991–1003.
92. A.Lohani, G.Singh, S.S.Bhattacharya, et al. Interpenetrating polymer networks as innovative drug delivery systems. J Drug Deliv. 2014;2014:11. Article ID 583612. In-depth review of the use of IPNs in novel drug delivery systems.
93. H.P.James, R.John, A.Alex, et al. Smart polymers for the controlled delivery of drugs – a concise overview. Acta Pharmaceutica Sinica B. 2014;4:120–127.• Well-balanced article providing insight into the advantages and challenges of stimuli-responsive drug delivery systems.
94. M.D.Bentley, X.Zhao, Shearwater Corporation. Hydrogels derived from chitosan and poly(ethylene glycol) or related polymers. US 6,602,952 B1. 2003.
95. M.Kurisawa, F.Lee, Agency for Science, Technology and Research. Interpenetrating polymer network comprising fibrin. US 8,853,162 B2. 2014.